spacer
spacer

PDBsum entry 1e1h

Go to PDB code: 
protein metals Protein-protein interface(s) links
Hydrolase PDB id
1e1h

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
235 a.a. *
164 a.a. *
Metals
_ZN ×2
Waters ×768
* Residue conservation analysis
PDB id:
1e1h
Name: Hydrolase
Title: Crystal structure of recombinant botulinum neurotoxin type a light chain, self-inhibiting zn endopeptidase.
Structure: Botulinum neurotoxin type a light chain. Chain: a, c. Fragment: residues 10-250. Synonym: bont/a lc. Engineered: yes. Botulinum neurotoxin type a light chain. Chain: b, d. Fragment: residues 252-416. Synonym: bont/a lc.
Source: Clostridium botulinum. Organism_taxid: 1491. Strain: kyoto-f. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_variant: blr de-3.
Biol. unit: Tetramer (from PDB file)
Resolution:
1.80Å     R-factor:   0.196     R-free:   0.237
Authors: M.Knapp,B.Rupp
Key ref:
B.Segelke et al. (2004). Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity. Proc Natl Acad Sci U S A, 101, 6888-6893. PubMed id: 15107500 DOI: 10.1073/pnas.0400584101
Date:
08-May-00     Release date:   19-Jun-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q45894  (BXA2_CLOBJ) -  Botulinum neurotoxin type A2 from Clostridium botulinum (strain Kyoto / Type A2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1296 a.a.
235 a.a.*
Protein chains
Pfam   ArchSchema ?
Q45894  (BXA2_CLOBJ) -  Botulinum neurotoxin type A2 from Clostridium botulinum (strain Kyoto / Type A2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1296 a.a.
164 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D: E.C.3.4.24.69  - bontoxilysin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
      Cofactor: Zn(2+)

 

 
DOI no: 10.1073/pnas.0400584101 Proc Natl Acad Sci U S A 101:6888-6893 (2004)
PubMed id: 15107500  
 
 
Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.
B.Segelke, M.Knapp, S.Kadkhodayan, R.Balhorn, B.Rupp.
 
  ABSTRACT  
 
Clostridium botulinum neurotoxins (BoNTs), the most potent toxins known, disrupt neurotransmission through proteolysis of proteins involved in neuroexocytosis. The light chains of BoNTs are unique zinc proteases that have stringent substrate specificity and require exceptionally long substrates. We have determined the crystal structure of the protease domain from BoNT serotype A (BoNT/A). The structure reveals a homodimer in a product-bound state, with loop F242-V257 from each monomer deeply buried in its partner's catalytic site. The loop, which acts as a substrate, is oriented in reverse of the canonical direction for other zinc proteases. The Y249-Y250 peptide bond of the substrate loop is hydrolyzed, leaving the Y249 product carboxylate coordinated to the catalytic zinc. From the crystal structure of the BoNT/A protease, detailed models of noncanonical binding and proteolysis can be derived which we propose are also consistent with BoNT/A binding and proteolysis of natural substrate synaptosome-associated protein of 25 kDa (SNAP-25). The proposed BoNT/A substrate-binding mode and catalytic mechanism are markedly different from those previously proposed for the BoNT serotype B.
 
  Selected figure(s)  
 
Figure 4.
Fig. 4. The S1' specificity pocket. A ball-and-stick representation of a modeled interaction between P1' and S1' for the homodimer with Y250 in the proposed S1' pocket. Hydrogen bonds and ionic interactions are highlighted with yellow dashes. This figure was generated with MIDAS (36).
Figure 5.
Fig. 5. Catalytic mechanism. (a) A stereo view of thermolysin residues [yellow, with side chain O atoms, red, and side chain N atoms, blue; PDB 1TMN [PDB] (28)] involved in catalysis is shown superimposed on the homologous residues from BoNT/A (shown in cyan). P1 and P2 of the cleavage product from pseudosubstrate are also shown with the product carboxylate coordinated to the catalytic zinc. BoNT/A LC Y365 (magenta) is shown in the conformation from holotoxin. This figure was generated with MIDAS (36). (b) A schematic illustration of the proposed catalytic mechanism of 250s loop hydrolysis in the BoNT/A homodimer is shown. This figure was generated with ISIS DRAW.
 
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
23268232 W.I.Lipkin (2013).
The changing face of pathogen discovery and surveillance.
  Nat Rev Microbiol, 11, 133-141.  
21078393 G.Masuyer, M.Beard, V.A.Cadd, J.A.Chaddock, and K.R.Acharya (2011).
Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
  J Struct Biol, 174, 52-57.
PDB code: 2xhl
20693440 H.H.Wang, S.Riding, P.Lindo, and B.R.Singh (2010).
Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
  Appl Environ Microbiol, 76, 6658-6663.  
20233039 M.Montal (2010).
Botulinum neurotoxin: a marvel of protein design.
  Annu Rev Biochem, 79, 591-617.  
20169001 Y.Fujinaga (2010).
Interaction of botulinum toxin with the epithelial barrier.
  J Biomed Biotechnol, 2010, 974943.  
19164566 A.Fischer, Y.Nakai, L.M.Eubanks, C.M.Clancy, W.H.Tepp, S.Pellett, T.J.Dickerson, E.A.Johnson, K.D.Janda, and M.Montal (2009).
Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
  Proc Natl Acad Sci U S A, 106, 1330-1335.  
18798567 L.Maveyraud, H.Niwa, V.Guillet, D.I.Svergun, P.V.Konarev, R.A.Palmer, W.J.Peumans, P.Rougé, E.J.Van Damme, C.D.Reynolds, and L.Mourey (2009).
Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra.
  Proteins, 75, 89.
PDB codes: 3c9z 3ca0 3ca1 3ca3 3ca4 3ca5 3ca6 3cah
19111565 M.Montal (2009).
Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.
  Toxicon, 54, 565-569.  
19129860 Q.Xu, M.E.Pichichero, L.L.Simpson, M.Elias, L.A.Smith, and M.Zeng (2009).
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.
  Gene Ther, 16, 367-375.  
19528275 V.Roxas-Duncan, I.Enyedy, V.A.Montgomery, V.S.Eccard, M.A.Carrington, H.Lai, N.Gul, D.C.Yang, and L.A.Smith (2009).
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.
  Antimicrob Agents Chemother, 53, 3478-3486.  
18658150 R.Agarwal, and S.Swaminathan (2008).
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
  J Biol Chem, 283, 25944-25951.
PDB code: 3d3x
17907800 A.T.Brunger, M.A.Breidenbach, R.Jin, A.Fischer, J.S.Santos, and M.Montal (2007).
Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.
  PLoS Pathog, 3, 1191-1194.  
17524984 N.R.Silvaggi, G.E.Boldt, M.S.Hixon, J.P.Kennedy, S.Tzipori, K.D.Janda, and K.N.Allen (2007).
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.
  Chem Biol, 14, 533-542.
PDB codes: 2ilp 2ima 2imb 2imc
  16785103 B.R.Singh (2006).
Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.
  Neurotox Res, 9, 73-92.  
17115255 S.Cai, R.Kukreja, S.Shoesmith, T.W.Chang, and B.R.Singh (2006).
Botulinum neurotoxin light chain refolds at endosomal pH for its translocation.
  Protein J, 25, 455-462.  
15988765 C.Anne, S.Turcaud, A.G.Blommaert, F.Darchen, E.A.Johnson, and B.P.Roques (2005).
Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.
  Chembiochem, 6, 1375-1380.  
15803193 J.C.Burnett, E.A.Henchal, A.L.Schmaljohn, and S.Bavari (2005).
The evolving field of biodefence: therapeutic developments and diagnostics.
  Nat Rev Drug Discov, 4, 281-297.  
16008342 J.W.Arndt, W.Yu, F.Bi, and R.C.Stevens (2005).
Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
  Biochemistry, 44, 9574-9580.
PDB code: 1zb7
16006188 M.A.Breidenbach, and A.T.Brunger (2005).
New insights into clostridial neurotoxin-SNARE interactions.
  Trends Mol Med, 11, 377-381.  
15592454 M.A.Breidenbach, and A.T.Brunger (2004).
Substrate recognition strategy for botulinum neurotoxin serotype A.
  Nature, 432, 925-929.
PDB codes: 1xtf 1xtg
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer